1-5 of 5
Keywords: inflammatory bowel disease
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Biochem Soc Trans (2022) 50 (1): 223–230.
Published: 15 February 2022
... the bioactivity of the IL-36 subfamily and its role in the pathogenesis of intestinal diseases such as inflammatory bowel disease, colorectal cancer, gut dysbacteriosis and infection, and proposes that IL-36 may be a target for novel therapeutic strategies to prevent or treat intestinal diseases...
Biochem Soc Trans (2021) 49 (5): 2371–2380.
Published: 28 September 2021
.... ILC2 inflammatory bowel disease mucosal immunology T H 2 type 2 immunity IBD is characterized by activation of T cell-derived pro-inflammatory cytokines, such as IL-17 [ 8 ], TNFα [ 9 ], and IFN-γ [ 10 , 11 ], as well as malfunction of peripheral- and tissue-specific regulatory T cells [ 12...
Biochem Soc Trans (2012) 40 (5): 1039–1041.
Published: 19 September 2012
...Patrick A. Lewis; Dario R. Alessi LRRK2 (leucine-rich repeat kinase 2) is a gene of unknown function that has been linked to a number a human diseases, including PD (Parkinson's disease), IBD (inflammatory bowel disease), leprosy and cancer. The papers from the LRRK2: Function and Dysfunction...
Biochem Soc Trans (2011) 39 (4): 1096–1101.
Published: 20 July 2011
... of intestinal parasites or micro-organisms from an evolutionary point of view. The Molecular Biology of Inflammatory Bowel Diseases: A Biochemical Society Focused Meeting held at University of Durham, Durham, U.K., 20–22 March 2011. Organized and Edited by Tony Corfield (Bristol, U.K.), Chris Probert...
Biochem Soc Trans (2011) 39 (4): 1092–1095.
Published: 20 July 2011
...Alexander J.P. Edwards; Sylvia L.F. Pender IBDs (inflammatory bowel diseases) are lifelong manifestations that significantly impair the quality of life of those who suffer from them. Although many therapies are now available, including immunomodulatory drugs such as Infliximab which have efficacy...